Sign in
Taking people in United StatesNo phase

Sleep Coaching Program for Adults Living With Type 1 Diabetes

Tests a sleep coaching program in adults aged 18 to 40 with type 1 diabetes.

Key facts

Who runs it
Emory University
Where
Atlanta, United StatesSee the site
Trial code
Registry title
Health Behavior Intervention for Adults With Type 1 Diabetes
Status
Recruiting
People taking part
300 people, planned
Started
20 Dec 2023
Expected to end
Dec 2028
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • CB Sleep
Record updated
19 December 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults aged 18 to 40 with type 1 diabetes whose sleep is outside healthy ranges in at least one way. It tests a 12-week sleep program.

Age
18 to 40 years
Sex
All sexes can join.
Disease stage
Type 1 diabetes for at least 1 year, with one or more sleep health dimensions out of range.

Main reasons for not taking part

  • Does not speak English
  • A1C below 7% (53 mmol/mol)
  • More than 80% of time in glucose range

The registry criteria, word for word

Show all 5 criteriaShow less

Who can take part

  • Aged 18 to 40 years
  • Type 1 Diabetes at least 1 year
  • One or more sleep health dimension out of range

Who cannot take part

  • A1C < 7% or >80% time in glucose range
  • Non-English speaking

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 40 years old?

Where in United States

  • Emory UniversityAtlanta, United StatesContact: Stephanie Griggs, PhDTaking people

About the trial

What the trial wants to find out

Type 1 diabetes (T1D) affects approximately 2 million Americans, and only 2 in 8 young adults ages 18-31 years achieve glycemic targets (glycated hemoglobin A1C <7.0%). Achieving glycemic targets is associated with reduced risk of micro-and macrovascular complications. Sleep deprivation leads to impaired glucose tolerance and insulin sensitivity in adults without chronic conditions and with T1D. Promoting sleep in laboratory and natural environments contributes to improvements in insulin sensitivity, glucose levels, and distress symptoms in young adults without chronic conditions and more time in range in adolescents with T1D. Multiple dimensions of sleep health (alertness, timing, efficiency, and sleep duration) are associated with better achievement of glycemic targets in adults with T1D. Therefore, sleep health dimensions are appropriate therapeutic targets to improve glucoregulation and other diabetes self-management outcomes in this population.

Read full original descriptionShow less

Our primary objective is to evaluate the immediate and short-term effects of a 12-week CB-sleep intervention compared to enhanced usual care (time balanced attention control) on actigraphy- and self-report derived sleep health dimensions and diabetes self-management outcomes (glycemia and distress symptoms) over 9-months (Stage II of the NIH Model for Behavior Change, ORBIT phase III). CB-sleep is guided by principles and practices from motivational interviewing and the Transtheoretical Model of Behavior Change with interactive stage-matched sessions.

The 2 groups in the trial

  • CB-sleepTreatment being tested

    Initial instruction for the CB-sleep intervention will occur 60-minute telehealth session. The initial action planning session with a sleep report and booster sessions will be interactive and stage matched. The intervention will include an interactive PowerPoint with the participant's clinician sleep report with personalized feedback. They will be encouraged to systematically extend their time in bed by 1 hour and maintain the extension on both weekends and weekdays. Weekly titration will occur according to the following parameters: if sleep efficiency is ≥ 85%, time in bed is increased by 15 minutes per week until a total of a 1 hour increase in time in bed is achieved, if sleep efficiency is \<85%, time in bed remains the same. There will be weekly follow-ups (email, phone, text, video chat) and telehealth 4-week booster sessions. Sleep reports generated by the baseline actigraphy report will be shared with participants with brief action planning and goal setting.

  • Attention Control Enhanced Usual Care armNo study treatment, for comparison

    After baseline, the RA assigned to this condition will schedule a 60-minute telehealth appointment to provide instruction for enhanced usual care at the initial consultation visit via contact at T1 (60-minute telehealth session in a private location). The time-balanced follow-up sessions will remain neutral and focused on health perceptions, current plan of care, and relationship building as opposed to the CB-sleep condition's focus on sleep promotion and extension. The RA assigned to the control condition will ask participants to (a) describe how they are doing and (b) ask how confident they are in achieving the goals they have set for themselves. These calls will help to build a relationship with participants to promote study retention. The investigators recognize that participants may obtain self-initiated diabetes self-management in this group, which will vary and will use a Diabetes Self-Management Tracking Form to monitor weekly information acquisition.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Health Behavior Intervention for Adults With Type 1 Diabetes
Plain-language title
Sleep Coaching Program for Adults Living With Type 1 DiabetesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT05823142, who can take part
Record updated
19 December 2025